These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3652005)

  • 1. New subgrouping of small thyroid carcinomas.
    Kasai N; Sakamoto A
    Cancer; 1987 Oct; 60(8):1767-70. PubMed ID: 3652005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
    Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
    Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
    Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
    Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lymph node dissection in non-medullary differentiated thyroid carcinoma].
    Mathonnet M
    Ann Chir; 2006; 131(6-7):361-8. PubMed ID: 16329987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological studies of minimal thyroid and ordinary thyroid cancers.
    Noguchi M; Tanaka S; Akiyama T; Miyazaki I; Michigishi T; Tonami N; Hisada K; Terahata S; Matsubara F
    Jpn J Surg; 1984 Mar; 14(2):110-7. PubMed ID: 6748382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.
    Chang HY; Lin JD; Chou SC; Chao TC; Hsueh C
    Jpn J Clin Oncol; 2006 Nov; 36(11):688-93. PubMed ID: 17000702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostically relevant factors in follicular thyroid cancer].
    Böttger T; Klupp J; Sorger K; Junginger T
    Langenbecks Arch Chir; 1990; 375(5):266-71. PubMed ID: 2259260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular variant of thyroid papillary carcinoma: a clinicopathologic study of six cases.
    Chem KT; Rosai J
    Am J Surg Pathol; 1977 Jun; 1(2):123-30. PubMed ID: 602974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidental cervical metastases from thyroid carcinoma during neck dissection.
    Périé S; Torti F; Lefevre M; Chabbert-Buffet N; Jafari A; Lacau St Guily J
    Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Dec; 133(6):383-386. PubMed ID: 27474239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis--a meta-analysis].
    Witte J; Schlotmann U; Simon D; Dotzenrath C; Ohmann C; Goretzki PE
    Zentralbl Chir; 1997; 122(4):259-65. PubMed ID: 9221636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
    Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
    Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical treatment of metastatic papillary thyroid carcinoma in cervical lymph nodal with occult primary sites].
    Pang YJ; Chen XH; Zhang JY; Gao JL
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jul; 31(13):1013-1016. PubMed ID: 29798166
    [No Abstract]   [Full Text] [Related]  

  • 14. Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.
    Nie X; Tan Z; Ge M
    BMC Cancer; 2017 Oct; 17(1):702. PubMed ID: 29070029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection.
    Chung YS; Kim JY; Bae JS; Song BJ; Kim JS; Jeon HM; Jeong SS; Kim EK; Park WC
    Thyroid; 2009 Mar; 19(3):241-6. PubMed ID: 19265495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection.
    Ito Y; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
    World J Surg; 2007 Nov; 31(11):2085-91. PubMed ID: 17885787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
    Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.
    Mercante G; Frasoldati A; Pedroni C; Formisano D; Renna L; Piana S; Gardini G; Valcavi R; Barbieri V
    Thyroid; 2009 Jul; 19(7):707-16. PubMed ID: 19348581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
    Rosário PW; Calsolari MR
    Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What should we do? Papillary thyroid carcinoma in a lymph node but normal thyroid tissue--how should we proceed?
    Flanagan D; Gibb P; Skene A; McCutcheon J; Armitage M
    Eur J Surg Oncol; 2000 Mar; 26(2):177-80. PubMed ID: 10744940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.